Latest From Biotech Now

The U.S. Government’s Position in ACLU v. Myriad Genetics

Hans Sauer BTN

Hans Sauer, BIO’s Deputy General Counsel for Intellectual Property, comments on  the Department of Justice’s brief and oral argument in the Myriad “gene patent” case.  Read his guest collumn on IPWatchdog. I have often wondered why the DOJ showed up out of nowhere two years ago, and started pressing legal theories that are contrary to decades of U.S. government policy and established patent law, and that would potentially invalidate thousands of patents to DNA molecules, enzymes, Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

2 FIELDS 1 GOAL: Protecting the Integrity of Science and Sport

Track

In just over a week, the eyes of the world will fall on London as the city hosts the opening ceremonies for the 2012 Summer Olympics.  Millions of people from around the globe will watch in awe as the world’s greatest athletes enthrall and inspire us, remind us of our common humanity and showcase the triumph of the human spirit as these amazing athletes push the limits of their physical capabilities. Sadly, some competitors succumb Read More >

Jim's Corner  |  Leave a comment  |  Email This Post
Tags: , , , , ,

Just What the Doctor Ordered: Biotech’s Improved Apple

Arctic Apple

There’s a lot of buzz right now over the new “Arctic Apple,” genetically engineered to resist browning due to cutting, biting and bruising.   The Golden Delicious and Granny Smith apples developed by Okanagan Specialty Fruits Inc. (OSF) are exactly like a conventional apple in every way, except for its improved trait, that will – hopefully – increase apple consumption and popularity. The U.S. Department of Agriculture’s Animal and Plant Health Inspection Service (USDA APHIS) recently Read More >

Farmer Gene  |  1 Comment  |  Email This Post
Tags: , , , , , ,

Patent Evergreening in India: Response from the Other Side

Plant

Thank you Adriana for commenting on my article Patent “Ever-Greening”: Novartis Confronts Patent Myth in India.  Before I respond, here is your full comment: Adriana says: While patients in India may still be able to access a generic form of off-patent imatinib mesylate (Glivec) if Novartis wins their legal challenge (because this “original form” was never patented in India due to India’s patent law not allowing product patents on medicines prior to 2005), a legal Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , ,

Silk Improves Vaccine Longevity

silkvaxtoney

Who doesn’t love the feel of silk fabric? Dresses, ties, sofa upholstery- you name it, we can’t keep our hands off it. You may have also heard that silk is an excellent surgical material for sutures, bandages, and implants. But did you know that our favorite fiber may not only patch up the world, but heal it as well? Here’s the problem we face: Many vaccines need to be kept cold in order to work Read More >

Health  |  Leave a comment  |  Email This Post
Tags: , , ,